Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.21 $525,914 - $945,215
71,553 New
71,553 $525,000
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $6,328 - $11,277
315 New
315 $7,000
Q1 2022

May 13, 2022

SELL
$36.48 - $52.22 $3,647 - $5,222
-100 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$33.11 - $55.01 $3,311 - $5,501
100 New
100 $4,000
Q3 2021

Nov 12, 2021

SELL
$50.07 - $66.05 $300 - $396
-6 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$56.61 - $80.46 $339 - $482
6 New
6 $0

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.